| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.19e-09 | 5 | 80 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 8.28e-09 | 7 | 80 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 8.28e-09 | 7 | 80 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 4.92e-08 | 10 | 80 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 4.92e-08 | 10 | 80 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 4.92e-08 | 10 | 80 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.66e-07 | 13 | 80 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.39e-06 | 24 | 80 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 3.91e-06 | 27 | 80 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.14e-05 | 35 | 80 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 1.59e-05 | 2 | 80 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 1.59e-05 | 2 | 80 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.96e-05 | 40 | 80 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | arachidonate binding | 2.72e-05 | 15 | 80 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 3.34e-05 | 16 | 80 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 3.34e-05 | 16 | 80 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 4.41e-05 | 49 | 80 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity | 4.74e-05 | 3 | 80 | 2 | GO:0008489 | |
| GeneOntologyMolecularFunction | N-acetyllactosamine synthase activity | 1.57e-04 | 5 | 80 | 2 | GO:0003945 | |
| GeneOntologyMolecularFunction | exogenous lipid antigen binding | 1.57e-04 | 5 | 80 | 2 | GO:0030884 | |
| GeneOntologyMolecularFunction | endogenous lipid antigen binding | 1.57e-04 | 5 | 80 | 2 | GO:0030883 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.69e-04 | 27 | 80 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.79e-04 | 70 | 80 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.89e-04 | 28 | 80 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 2.35e-04 | 6 | 80 | 2 | GO:0030882 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 2.57e-04 | 31 | 80 | 3 | GO:0004181 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 2.82e-04 | 32 | 80 | 3 | GO:0035250 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 3.70e-04 | 35 | 80 | 3 | GO:0008378 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.78e-04 | 85 | 80 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.39e-04 | 172 | 80 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 6.99e-04 | 10 | 80 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | tau protein binding | 8.30e-04 | 46 | 80 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 9.99e-04 | 49 | 80 | 3 | GO:0004180 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 9.99e-04 | 110 | 80 | 4 | GO:0008238 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 1.02e-03 | 12 | 80 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.10e-03 | 194 | 80 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.18e-03 | 115 | 80 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | dipeptidase activity | 2.33e-03 | 18 | 80 | 2 | GO:0016805 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 2.59e-03 | 19 | 80 | 2 | GO:0031434 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.68e-03 | 69 | 80 | 3 | GO:0005504 | |
| GeneOntologyMolecularFunction | heme binding | 3.42e-03 | 154 | 80 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | collagen binding | 4.22e-03 | 81 | 80 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 4.27e-03 | 164 | 80 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 4.46e-03 | 166 | 80 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 6.20e-03 | 93 | 80 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 8.54e-03 | 200 | 80 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 9.12e-03 | 107 | 80 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activator activity | 9.14e-03 | 36 | 80 | 2 | GO:0030296 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 9.61e-03 | 207 | 80 | 4 | GO:0008236 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.02e-02 | 600 | 80 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.03e-02 | 211 | 80 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.04e-02 | 212 | 80 | 4 | GO:0017171 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.29e-09 | 6 | 81 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 7.65e-09 | 7 | 81 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 1.53e-08 | 8 | 81 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 5.83e-08 | 3 | 81 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 7.13e-08 | 11 | 81 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 1.07e-07 | 12 | 81 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 2.33e-07 | 4 | 81 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 2.33e-07 | 4 | 81 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 2.33e-07 | 4 | 81 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 2.33e-07 | 4 | 81 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 1.16e-06 | 6 | 81 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 1.16e-06 | 6 | 81 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 1.53e-06 | 22 | 81 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 9.41e-06 | 11 | 81 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 1.25e-05 | 12 | 81 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.77e-05 | 82 | 81 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 2.00e-05 | 41 | 81 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 2.06e-05 | 14 | 81 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 4.56e-05 | 18 | 81 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 7.37e-05 | 21 | 81 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 9.09e-05 | 4 | 81 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.48e-04 | 68 | 81 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 1.49e-04 | 128 | 81 | 5 | GO:0033559 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | 1.51e-04 | 5 | 81 | 2 | GO:0048006 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule binding | 1.51e-04 | 5 | 81 | 2 | GO:1904528 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.96e-04 | 73 | 81 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | ganglioside biosynthetic process via lactosylceramide | 2.26e-04 | 6 | 81 | 2 | GO:0010706 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 2.26e-04 | 6 | 81 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 2.43e-04 | 142 | 81 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 2.78e-04 | 228 | 81 | 6 | GO:0046777 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 3.16e-04 | 7 | 81 | 2 | GO:0048007 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of lipid antigen via MHC class Ib | 3.16e-04 | 7 | 81 | 2 | GO:0048003 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 4.36e-04 | 90 | 81 | 4 | GO:0140962 | |
| GeneOntologyBiologicalProcess | regulation of microtubule binding | 5.39e-04 | 9 | 81 | 2 | GO:1904526 | |
| GeneOntologyBiologicalProcess | disaccharide metabolic process | 9.80e-04 | 12 | 81 | 2 | GO:0005984 | |
| GeneOntologyBiologicalProcess | iron import into cell | 9.80e-04 | 12 | 81 | 2 | GO:0033212 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 1.06e-03 | 51 | 81 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 1.13e-03 | 116 | 81 | 4 | GO:0009062 | |
| Domain | TFR_dimer | 1.34e-06 | 6 | 77 | 3 | PF04253 | |
| Domain | - | 1.34e-06 | 6 | 77 | 3 | 1.20.930.40 | |
| Domain | Galactosyl_T | 2.33e-06 | 7 | 77 | 3 | IPR003859 | |
| Domain | TFR-like_dimer_dom | 2.33e-06 | 7 | 77 | 3 | IPR007365 | |
| Domain | Glyco_transf_7C | 2.33e-06 | 7 | 77 | 3 | PF02709 | |
| Domain | Glyco_transf_7N | 2.33e-06 | 7 | 77 | 3 | PF13733 | |
| Domain | Galactosyl_T_C | 2.33e-06 | 7 | 77 | 3 | IPR027791 | |
| Domain | Galactosyl_T_N | 2.33e-06 | 7 | 77 | 3 | IPR027995 | |
| Domain | Peptidase_M28 | 1.44e-05 | 12 | 77 | 3 | IPR007484 | |
| Domain | Peptidase_M28 | 1.44e-05 | 12 | 77 | 3 | PF04389 | |
| Domain | TyrKc | 3.13e-05 | 88 | 77 | 5 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.13e-05 | 88 | 77 | 5 | IPR020635 | |
| Domain | Cyt_P450_E_grp-I | 3.50e-05 | 45 | 77 | 4 | IPR002401 | |
| Domain | PA | 6.23e-05 | 19 | 77 | 3 | PF02225 | |
| Domain | PA_domain | 6.23e-05 | 19 | 77 | 3 | IPR003137 | |
| Domain | Cyt_P450_CS | 6.71e-05 | 53 | 77 | 4 | IPR017972 | |
| Domain | SRCR | 8.49e-05 | 21 | 77 | 3 | PF00530 | |
| Domain | CYTOCHROME_P450 | 8.94e-05 | 57 | 77 | 4 | PS00086 | |
| Domain | - | 9.57e-05 | 58 | 77 | 4 | 1.10.630.10 | |
| Domain | p450 | 9.57e-05 | 58 | 77 | 4 | PF00067 | |
| Domain | MLK1/MLK2/MLK4 | 1.00e-04 | 4 | 77 | 2 | IPR016231 | |
| Domain | MAP3K10 | 1.00e-04 | 4 | 77 | 2 | IPR015785 | |
| Domain | Cyt_P450 | 1.09e-04 | 60 | 77 | 4 | IPR001128 | |
| Domain | SR | 1.45e-04 | 25 | 77 | 3 | SM00202 | |
| Domain | - | 1.45e-04 | 25 | 77 | 3 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.64e-04 | 26 | 77 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.64e-04 | 26 | 77 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 1.64e-04 | 26 | 77 | 3 | IPR017448 | |
| Domain | SRCR | 1.84e-04 | 27 | 77 | 3 | IPR001190 | |
| Domain | Pkinase_Tyr | 1.93e-04 | 129 | 77 | 5 | PF07714 | |
| Domain | MHC_I_3 | 2.49e-04 | 6 | 77 | 2 | PF16497 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.64e-04 | 138 | 77 | 5 | IPR001245 | |
| Domain | - | 6.92e-04 | 97 | 77 | 4 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 7.47e-04 | 99 | 77 | 4 | IPR016186 | |
| Domain | CTDL_fold | 9.99e-04 | 107 | 77 | 4 | IPR016187 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 1.27e-03 | 13 | 77 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 1.27e-03 | 13 | 77 | 2 | PS00125 | |
| Domain | PP2Ac | 1.27e-03 | 13 | 77 | 2 | SM00156 | |
| Domain | PROTEIN_KINASE_ATP | 2.83e-03 | 459 | 77 | 7 | PS00107 | |
| Domain | Prot_kinase_dom | 4.01e-03 | 489 | 77 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 4.19e-03 | 493 | 77 | 7 | PS50011 | |
| Domain | - | 4.37e-03 | 24 | 77 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 4.37e-03 | 24 | 77 | 2 | IPR011161 | |
| Domain | C_TYPE_LECTIN_1 | 4.41e-03 | 80 | 77 | 3 | PS00615 | |
| Domain | - | 4.56e-03 | 81 | 77 | 3 | 3.90.550.10 | |
| Domain | SH3_1 | 4.72e-03 | 164 | 77 | 4 | PF00018 | |
| Domain | Protein_kinase_ATP_BS | 4.74e-03 | 379 | 77 | 6 | IPR017441 | |
| Domain | Lectin_C | 5.05e-03 | 84 | 77 | 3 | PF00059 | |
| Domain | CLECT | 5.05e-03 | 84 | 77 | 3 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 5.22e-03 | 85 | 77 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 5.39e-03 | 86 | 77 | 3 | IPR001304 | |
| Domain | SPRY | 5.57e-03 | 87 | 77 | 3 | SM00449 | |
| Domain | Nucleotide-diphossugar_trans | 5.75e-03 | 88 | 77 | 3 | IPR029044 | |
| Domain | Calcineurin-like_PHP_ApaH | 5.92e-03 | 28 | 77 | 2 | IPR004843 | |
| Domain | Metallophos | 5.92e-03 | 28 | 77 | 2 | PF00149 | |
| Domain | ArfGap | 6.34e-03 | 29 | 77 | 2 | SM00105 | |
| Domain | ArfGap | 6.34e-03 | 29 | 77 | 2 | PF01412 | |
| Domain | ARFGAP | 6.34e-03 | 29 | 77 | 2 | PS50115 | |
| Domain | ArfGAP | 6.34e-03 | 29 | 77 | 2 | IPR001164 | |
| Domain | Metallo-depent_PP-like | 6.77e-03 | 30 | 77 | 2 | IPR029052 | |
| Domain | - | 6.77e-03 | 30 | 77 | 2 | 3.60.21.10 | |
| Domain | SPRY | 6.90e-03 | 94 | 77 | 3 | PF00622 | |
| Domain | SPRY_dom | 6.90e-03 | 94 | 77 | 3 | IPR003877 | |
| Domain | Kinase-like_dom | 6.96e-03 | 542 | 77 | 7 | IPR011009 | |
| Domain | B30.2/SPRY | 7.11e-03 | 95 | 77 | 3 | IPR001870 | |
| Domain | B302_SPRY | 7.11e-03 | 95 | 77 | 3 | PS50188 | |
| Pathway | REACTOME_EICOSANOIDS | 1.43e-07 | 12 | 60 | 4 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 1.43e-07 | 12 | 60 | 4 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 2.87e-07 | 14 | 60 | 4 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 3.91e-07 | 15 | 60 | 4 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 8.68e-07 | 18 | 60 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 8.68e-07 | 18 | 60 | 4 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.51e-06 | 25 | 60 | 4 | MM14858 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 5.84e-06 | 61 | 60 | 5 | MM14861 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.11e-05 | 33 | 60 | 4 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.11e-05 | 33 | 60 | 4 | MM15963 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.18e-05 | 11 | 60 | 3 | MM14863 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.57e-05 | 12 | 60 | 3 | M27128 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.80e-05 | 288 | 60 | 8 | M16864 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 3.22e-05 | 15 | 60 | 3 | MM15700 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 3.22e-05 | 15 | 60 | 3 | M966 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 9.23e-05 | 21 | 60 | 3 | M27137 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 9.23e-05 | 21 | 60 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 9.23e-05 | 21 | 60 | 3 | MM14996 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.13e-04 | 59 | 60 | 4 | M27140 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.38e-04 | 62 | 60 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.56e-04 | 64 | 60 | 4 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.75e-04 | 66 | 60 | 4 | MM14839 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | 1.78e-04 | 26 | 60 | 3 | M979 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 2.23e-04 | 28 | 60 | 3 | M670 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 2.23e-04 | 28 | 60 | 3 | MM14798 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | 2.48e-04 | 29 | 60 | 3 | MM15699 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 3.69e-04 | 7 | 60 | 2 | M26992 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.99e-04 | 34 | 60 | 3 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.35e-04 | 35 | 60 | 3 | MM15271 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.74e-04 | 36 | 60 | 3 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.74e-04 | 36 | 60 | 3 | MM14632 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 6.29e-04 | 9 | 60 | 2 | M39819 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.69e-04 | 170 | 60 | 5 | MM15573 | |
| Pathway | REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION | 7.84e-04 | 10 | 60 | 2 | M27176 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 7.84e-04 | 10 | 60 | 2 | MM14509 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 8.57e-04 | 44 | 60 | 3 | MM15377 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 9.56e-04 | 11 | 60 | 2 | M27836 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 9.56e-04 | 11 | 60 | 2 | M1091 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 9.93e-04 | 104 | 60 | 4 | M738 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.00e-03 | 271 | 60 | 6 | MM15406 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.03e-03 | 105 | 60 | 4 | MM14842 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 1.04e-03 | 47 | 60 | 3 | M29724 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.07e-03 | 183 | 60 | 5 | M39588 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.11e-03 | 48 | 60 | 3 | MM15902 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 1.14e-03 | 12 | 60 | 2 | M27950 | |
| Pathway | REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM | 1.14e-03 | 12 | 60 | 2 | MM15556 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 1.14e-03 | 12 | 60 | 2 | M47929 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 1.35e-03 | 13 | 60 | 2 | MM14811 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 1.35e-03 | 13 | 60 | 2 | M8410 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 1.35e-03 | 13 | 60 | 2 | M1015 | |
| Pathway | WP_DOPAMINE_METABOLISM | 1.35e-03 | 13 | 60 | 2 | M39622 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 1.81e-03 | 15 | 60 | 2 | M27407 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.85e-03 | 123 | 60 | 4 | MM14623 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 1.92e-03 | 58 | 60 | 3 | M5410 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 2.02e-03 | 126 | 60 | 4 | M695 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 2.06e-03 | 16 | 60 | 2 | M47870 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.06e-03 | 16 | 60 | 2 | MM14699 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 2.06e-03 | 16 | 60 | 2 | MM14541 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 2.06e-03 | 16 | 60 | 2 | M514 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 2.33e-03 | 17 | 60 | 2 | MM15096 | |
| Pathway | WP_IRON_METABOLISM_DISORDERS | 2.33e-03 | 17 | 60 | 2 | M48053 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 2.33e-03 | 17 | 60 | 2 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 2.33e-03 | 17 | 60 | 2 | M919 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.36e-03 | 219 | 60 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.41e-03 | 220 | 60 | 5 | M10320 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 2.61e-03 | 18 | 60 | 2 | MM14759 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 2.77e-03 | 66 | 60 | 3 | MM14990 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS | 2.91e-03 | 19 | 60 | 2 | MM17075 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS | 2.91e-03 | 19 | 60 | 2 | M48041 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 2.91e-03 | 19 | 60 | 2 | M47525 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 2.91e-03 | 19 | 60 | 2 | MM14780 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 3.22e-03 | 20 | 60 | 2 | M47876 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 3.28e-03 | 70 | 60 | 3 | M8232 | |
| Pathway | WP_GLYCOSPHINGOLIPID_METABOLISM | 3.55e-03 | 21 | 60 | 2 | M46462 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 3.83e-03 | 74 | 60 | 3 | M17386 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 3.90e-03 | 22 | 60 | 2 | M13408 | |
| Pathway | REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION | 3.90e-03 | 22 | 60 | 2 | M6768 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.90e-03 | 22 | 60 | 2 | M47919 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 4.13e-03 | 76 | 60 | 3 | MM15051 | |
| Pathway | WP_16P112_PROXIMAL_DELETION_SYNDROME | 4.13e-03 | 76 | 60 | 3 | M40057 | |
| Pathway | REACTOME_DIGESTION | 4.26e-03 | 23 | 60 | 2 | M27790 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 4.55e-03 | 620 | 60 | 8 | MM15193 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 4.63e-03 | 24 | 60 | 2 | M751 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 5.02e-03 | 25 | 60 | 2 | M808 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 5.02e-03 | 25 | 60 | 2 | MM15379 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 3.01e-11 | 4 | 83 | 4 | 18065749 | |
| Pubmed | 4.51e-10 | 6 | 83 | 4 | 9068972 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 5.23e-08 | 4 | 83 | 3 | 11185557 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 1.31e-07 | 5 | 83 | 3 | 21466787 | |
| Pubmed | The expanding beta 4-galactosyltransferase gene family: messages from the databanks. | 2.61e-07 | 6 | 83 | 3 | 9597550 | |
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 22160543 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 5.63e-06 | 2 | 83 | 2 | 18662666 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 5.63e-06 | 2 | 83 | 2 | 2555176 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 10899914 | ||
| Pubmed | β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. | 5.63e-06 | 2 | 83 | 2 | 23882130 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 5.63e-06 | 2 | 83 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 5.63e-06 | 2 | 83 | 2 | 8026587 | |
| Pubmed | Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. | 5.63e-06 | 2 | 83 | 2 | 24498430 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 10543450 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11751260 | ||
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 5.63e-06 | 2 | 83 | 2 | 34902541 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 5.63e-06 | 2 | 83 | 2 | 2837763 | |
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 5.63e-06 | 2 | 83 | 2 | 1846293 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19371378 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15364545 | ||
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 5.63e-06 | 2 | 83 | 2 | 27096707 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19678840 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12204797 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30114188 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11113010 | ||
| Pubmed | GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond. | 5.63e-06 | 2 | 83 | 2 | 30844704 | |
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 10580128 | ||
| Pubmed | Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. | 1.69e-05 | 3 | 83 | 2 | 25216636 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10085079 | ||
| Pubmed | Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. | 1.69e-05 | 3 | 83 | 2 | 14551186 | |
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 1.69e-05 | 3 | 83 | 2 | 15145985 | |
| Pubmed | Partial characterization of murine intestinal maltase-glucoamylase. | 1.69e-05 | 3 | 83 | 2 | 12150962 | |
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 1.69e-05 | 3 | 83 | 2 | 8206937 | |
| Pubmed | Biochemical characterization of human glutamate carboxypeptidase III. | 1.69e-05 | 3 | 83 | 2 | 17241121 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33384157 | ||
| Pubmed | Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family. | 1.69e-05 | 3 | 83 | 2 | 17160644 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 37349952 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 38377674 | ||
| Pubmed | Inhibition of CD1 antigen presentation by human cytomegalovirus. | 1.69e-05 | 3 | 83 | 2 | 18287231 | |
| Pubmed | Separate pathways for antigen presentation by CD1 molecules. | 1.69e-05 | 3 | 83 | 2 | 10626896 | |
| Pubmed | CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. | 1.69e-05 | 3 | 83 | 2 | 16272286 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7510677 | ||
| Pubmed | Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase 3. | 1.69e-05 | 3 | 83 | 2 | 21908619 | |
| Pubmed | Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease. | 1.69e-05 | 3 | 83 | 2 | 15556687 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23468110 | ||
| Pubmed | Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. | 1.69e-05 | 3 | 83 | 2 | 2447586 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10441131 | ||
| Pubmed | Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. | 1.69e-05 | 3 | 83 | 2 | 23341017 | |
| Pubmed | Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. | 1.69e-05 | 3 | 83 | 2 | 23766460 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 8383590 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 15252037 | ||
| Pubmed | Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. | 2.24e-05 | 23 | 83 | 3 | 26644582 | |
| Pubmed | 2.45e-05 | 70 | 83 | 4 | 15128046 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 18624350 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11371618 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 21454489 | ||
| Pubmed | Antigen presentation by CD1 and MHC-encoded class I-like molecules. | 3.37e-05 | 4 | 83 | 2 | 8729450 | |
| Pubmed | The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. | 3.37e-05 | 4 | 83 | 2 | 14633983 | |
| Pubmed | Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. | 3.37e-05 | 4 | 83 | 2 | 24556395 | |
| Pubmed | Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. | 3.37e-05 | 4 | 83 | 2 | 21998041 | |
| Pubmed | Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. | 3.37e-05 | 4 | 83 | 2 | 9770493 | |
| Pubmed | Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. | 3.37e-05 | 4 | 83 | 2 | 7616230 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11145975 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 9920888 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 2701945 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 12415264 | ||
| Pubmed | 3.39e-05 | 76 | 83 | 4 | 22323595 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 3097645 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 10640627 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 18337560 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 5.60e-05 | 5 | 83 | 2 | 22632968 | |
| Pubmed | A physical map linking the five CD1 human thymocyte differentiation antigen genes. | 5.60e-05 | 5 | 83 | 2 | 2583117 | |
| Pubmed | CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. | 5.60e-05 | 5 | 83 | 2 | 11580851 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 10488738 | ||
| Pubmed | HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. | 5.60e-05 | 5 | 83 | 2 | 9009195 | |
| Pubmed | Protein phosphatase 2A interacts with and directly dephosphorylates RelA. | 5.60e-05 | 5 | 83 | 2 | 11591705 | |
| Pubmed | The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues. | 5.60e-05 | 5 | 83 | 2 | 16369487 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 23677998 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 15032598 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 18577768 | ||
| Pubmed | A gp130-Src-YAP module links inflammation to epithelial regeneration. | 5.60e-05 | 5 | 83 | 2 | 25731159 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 18596935 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 10781942 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 20606012 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 20100830 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 29735529 | ||
| Pubmed | The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation. | 8.39e-05 | 6 | 83 | 2 | 20603330 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 15147202 | ||
| Pubmed | STRIPAK components determine mode of cancer cell migration and metastasis. | 8.39e-05 | 6 | 83 | 2 | 25531779 | |
| Pubmed | Nesprin-2 is a novel scaffold protein for telethonin and FHL-2 in the cardiomyocyte sarcomere. | 8.39e-05 | 6 | 83 | 2 | 38569934 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 9647778 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 20561531 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 15713673 | ||
| Pubmed | The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development. | 1.17e-04 | 7 | 83 | 2 | 25546391 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 9949213 | ||
| Pubmed | X-linked microtubule-associated protein, Mid1, regulates axon development. | 1.17e-04 | 7 | 83 | 2 | 24194544 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 10698523 | ||
| Cytoband | 1q22-q23 | 2.49e-04 | 13 | 83 | 2 | 1q22-q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 2.74e-03 | 153 | 83 | 3 | chr11p11 | |
| Cytoband | Xq22.1 | 2.78e-03 | 43 | 83 | 2 | Xq22.1 | |
| Cytoband | 19p13.1 | 3.45e-03 | 48 | 83 | 2 | 19p13.1 | |
| GeneFamily | Cytochrome P450 family 4 | 4.85e-06 | 36 | 57 | 4 | 1003 | |
| GeneFamily | Beta 4-glycosyltransferases | 1.96e-05 | 17 | 57 | 3 | 425 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.74e-05 | 24 | 57 | 3 | 654 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 7.45e-04 | 13 | 57 | 2 | 693 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 1.79e-03 | 20 | 57 | 2 | 1371 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.26e-03 | 27 | 57 | 2 | 1253 | |
| GeneFamily | ArfGAPs | 4.84e-03 | 33 | 57 | 2 | 395 | |
| GeneFamily | C1-set domain containing | 7.75e-03 | 42 | 57 | 2 | 591 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.93e-03 | 394 | 57 | 5 | 471 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.12e-03 | 43 | 57 | 2 | 409 | |
| GeneFamily | C-type lectin domain family | 9.64e-03 | 47 | 57 | 2 | 494 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 2.72e-06 | 193 | 83 | 7 | M3484 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | B4GALT2 ADPRH IGFALS HPGDS AOPEP TREH TMPRSS3 PEDS1 CYP4F2 CYP4F12 CYP4F11 TMEM86A B4GALT6 RCN3 SPSB2 | 1.46e-05 | 1316 | 83 | 15 | MM1052 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.09e-05 | 479 | 83 | 9 | M2573 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | MGAM CD1C SSC4D ARAP3 CYBRD1 TIMP3 MRC2 DTX1 NEXMIF TMEM86A RCN3 | 2.15e-05 | 740 | 83 | 11 | M41202 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.23e-05 | 483 | 83 | 9 | MM1082 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | B4GALT2 ADPRH IGFALS HPGDS AOPEP TREH TMPRSS3 PEDS1 CYP4F2 CYP4F3 TMEM86A B4GALT6 RCN3 SPSB2 | 3.31e-05 | 1242 | 83 | 14 | M1920 |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 3.36e-05 | 20 | 83 | 3 | MM1104 | |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP | 3.79e-05 | 196 | 83 | 6 | M5189 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN | 4.12e-05 | 199 | 83 | 6 | M5206 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-08 | 187 | 83 | 7 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 198 | 83 | 6 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 198 | 83 | 6 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 198 | 83 | 6 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-06 | 198 | 83 | 6 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-06 | 199 | 83 | 6 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-06 | 199 | 83 | 6 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 157 | 83 | 5 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 1.61e-05 | 169 | 83 | 5 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 170 | 83 | 5 | 6ec0cf055ae55e9fac147f7989c47f83ab07270c | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 1.76e-05 | 172 | 83 | 5 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 173 | 83 | 5 | 31ea04e65876c42b90245d280f0b6439bfffbace | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 173 | 83 | 5 | 1cff815536f620e32b9805666e1aa711462c2d25 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.19e-05 | 180 | 83 | 5 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-05 | 181 | 83 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 182 | 83 | 5 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 182 | 83 | 5 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | Healthy-MAIT|Healthy / disease group, cell group and cell class | 2.56e-05 | 186 | 83 | 5 | 028061f06d86e75cb06db56b199594b80f23fa58 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.62e-05 | 187 | 83 | 5 | 23be50d81f4404a609dea821e1a66d221c0e0615 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | Healthy-MAIT|World / disease group, cell group and cell class | 2.76e-05 | 189 | 83 | 5 | 2404254b7a31b4a931841232e07462a3ca855ad4 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 2.83e-05 | 190 | 83 | 5 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.98e-05 | 192 | 83 | 5 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.05e-05 | 193 | 83 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | 95dfbd9d9b8a47801edcfc35fb0d685901dcd2f8 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | 2507f6dc7f1fe8b91fe1e24497d26d05afc3cd21 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-05 | 194 | 83 | 5 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-05 | 194 | 83 | 5 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 3.21e-05 | 195 | 83 | 5 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 195 | 83 | 5 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 195 | 83 | 5 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.29e-05 | 196 | 83 | 5 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-05 | 196 | 83 | 5 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-05 | 196 | 83 | 5 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 3.29e-05 | 196 | 83 | 5 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.29e-05 | 196 | 83 | 5 | b2aee2f67da373a10b0c25e7797e30e3811543a8 | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 196 | 83 | 5 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 196 | 83 | 5 | 1eb14182ef26e6141f510d397b00bf8a12efda3e | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.29e-05 | 196 | 83 | 5 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-05 | 196 | 83 | 5 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | distal-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-05 | 197 | 83 | 5 | 6fcca7c071e35786b715adeb18be317d34315d7e | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-05 | 197 | 83 | 5 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 3.45e-05 | 198 | 83 | 5 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.45e-05 | 198 | 83 | 5 | 898be90c906ebc806a764ae6c21bbf84649b6b30 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-05 | 199 | 83 | 5 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-05 | 199 | 83 | 5 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-05 | 199 | 83 | 5 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-05 | 199 | 83 | 5 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-05 | 199 | 83 | 5 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 3.53e-05 | 199 | 83 | 5 | dd61854de202c805100bad58f1ce08c3bd04bb58 | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.62e-05 | 200 | 83 | 5 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | 18-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 3.62e-05 | 200 | 83 | 5 | aca1e8def8ed6ae5749402d0288ad90656213de1 | |
| ToppCell | 11.5-Distal-Immune|Distal / Age, Tissue, Lineage and Cell class | 3.62e-05 | 200 | 83 | 5 | c9ed06ae7a8f5a88578c8269d762d8739ae79c7f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | 15-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 3.62e-05 | 200 | 83 | 5 | 13c4835b98e1bb91c2d04e08cdeaed8eba30b1d9 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.62e-05 | 200 | 83 | 5 | ee3d06865a6300e1279edf6664320b71647f5efb | |
| ToppCell | 367C-Fibroblasts|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 200 | 83 | 5 | c5aaa20c59b9f11b8abdf5de9e3fc54f4e6e39f7 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 125 | 83 | 4 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 9.08e-05 | 126 | 83 | 4 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 9.08e-05 | 126 | 83 | 4 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 139 | 83 | 4 | c320847311ba9a844fc4760251372a2a9152787b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-04 | 151 | 83 | 4 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Dendritic_Cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-04 | 151 | 83 | 4 | e089bf197ed60e7243160521d4390d4b40a3832b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 154 | 83 | 4 | 2d98bb7a784fc3215e0d4a1670d662e5df4716c3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 154 | 83 | 4 | 0dec222101530f1727184dbb7c03969d3884f111 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-04 | 155 | 83 | 4 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 155 | 83 | 4 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 2.02e-04 | 155 | 83 | 4 | 72c61be0a8d3ee10600a33c58fb01c35fd3f14d4 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 2.07e-04 | 156 | 83 | 4 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 2.07e-04 | 156 | 83 | 4 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 158 | 83 | 4 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 158 | 83 | 4 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.22e-04 | 159 | 83 | 4 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-04 | 160 | 83 | 4 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 161 | 83 | 4 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 161 | 83 | 4 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 161 | 83 | 4 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 161 | 83 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | droplet-Fat-Gat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 162 | 83 | 4 | 052f797d8bcab8fc6a43e0bffdd215c88ee12889 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-04 | 162 | 83 | 4 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.44e-04 | 163 | 83 | 4 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | Severe-Lymphoid-NK-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 2.44e-04 | 163 | 83 | 4 | 8f0d8c124f1569a5a6bc1db7581989f24d63cca3 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 164 | 83 | 4 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 164 | 83 | 4 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-04 | 165 | 83 | 4 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | Healthy_Control-Lymphoid-T-innate_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.56e-04 | 165 | 83 | 4 | 1ade67229b50fe20eb392262a3e1ee4306b73290 | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 2.56e-04 | 165 | 83 | 4 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-04 | 165 | 83 | 4 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 166 | 83 | 4 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 167 | 83 | 4 | e85d97f8b0127663a3295db2b22b8488c0148455 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 167 | 83 | 4 | ac21c7112b592e30473e693a2bbee81ff0bb0160 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 167 | 83 | 4 | 0d187e40a5b96b595761f7aea1a0835462d8270f | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 167 | 83 | 4 | a54e200789db14f41c9fc8d21cd7fa7cedde77ad | |
| Computational | Neighborhood of LCAT | 4.68e-05 | 124 | 57 | 6 | GNF2_LCAT | |
| Computational | Neighborhood of TST | 2.16e-04 | 104 | 57 | 5 | GNF2_TST | |
| Computational | Neighborhood of GSTM1 | 2.69e-04 | 109 | 57 | 5 | GNF2_GSTM1 | |
| Computational | Neighborhood of HPN | 6.96e-04 | 134 | 57 | 5 | GNF2_HPN | |
| Computational | Neighborhood of HPX | 7.20e-04 | 135 | 57 | 5 | GNF2_HPX | |
| Drug | dichloran | 3.20e-07 | 41 | 80 | 5 | CID000007430 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.61e-06 | 182 | 80 | 7 | 5010_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.69e-06 | 195 | 80 | 7 | 7441_DN | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; PC3; HT_HG-U133A | 6.49e-06 | 199 | 80 | 7 | 6686_UP | |
| Drug | 3 Cu | 1.22e-05 | 2 | 80 | 2 | CID009859098 | |
| Drug | nifedipine | 1.51e-05 | 415 | 80 | 9 | CID000004485 | |
| Drug | 2-PMPA | 2.26e-05 | 16 | 80 | 3 | CID010130754 | |
| Drug | isospaglumic acid | 3.65e-05 | 3 | 80 | 2 | ctd:C027172 | |
| Drug | casuarine | 3.65e-05 | 3 | 80 | 2 | CID000384347 | |
| Drug | alprazolam | 6.13e-05 | 193 | 80 | 6 | CID000002118 | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; HL60; HT_HG-U133A | 6.13e-05 | 193 | 80 | 6 | 3104_DN | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 5077_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 7361_UP | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 6.67e-05 | 196 | 80 | 6 | 253_UP | |
| Drug | clofibrate; Down 200; 100uM; MCF7; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 444_DN | |
| Drug | indomethacin, USP; Down 200; 100uM; SKMEL5; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 503_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 3831_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 3455_DN | |
| Drug | AC1MI1ZZ | 7.03e-05 | 23 | 80 | 3 | CID003036917 | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 7151_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 6183_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 4462_UP | |
| Drug | nimbidiol | 7.28e-05 | 4 | 80 | 2 | ctd:C496111 | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 7.46e-05 | 200 | 80 | 6 | 7308_DN | |
| Drug | hexobarbital | 8.58e-05 | 127 | 80 | 5 | CID000003608 | |
| Drug | AC1L1D63 | 9.09e-05 | 25 | 80 | 3 | CID000002209 | |
| Drug | ebastine | 9.09e-05 | 25 | 80 | 3 | CID000003191 | |
| Drug | propoxyphene | 9.15e-05 | 67 | 80 | 4 | CID000010100 | |
| Drug | delta-tocotrienol | 1.15e-04 | 27 | 80 | 3 | CID005282350 | |
| Drug | D-gluco-octenitol | 1.21e-04 | 5 | 80 | 2 | CID006438548 | |
| Drug | calystegine B(1 | 1.21e-04 | 5 | 80 | 2 | CID000164245 | |
| Drug | carteolol | 1.21e-04 | 72 | 80 | 4 | CID000002583 | |
| Drug | aminoglutethimide | 1.23e-04 | 137 | 80 | 5 | CID000002145 | |
| Disease | coffee consumption measurement, tea consumption measurement | 2.26e-04 | 44 | 79 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 2.52e-04 | 9 | 79 | 2 | EFO_0800562 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 6.65e-04 | 147 | 79 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Psychoses, Drug | 1.44e-03 | 21 | 79 | 2 | C0033937 | |
| Disease | Dwarfism | 2.04e-03 | 25 | 79 | 2 | C0013336 | |
| Disease | amygdala volume change measurement, age at assessment | 2.21e-03 | 26 | 79 | 2 | EFO_0008007, EFO_0021490 | |
| Disease | L lactate dehydrogenase measurement | 2.21e-03 | 26 | 79 | 2 | EFO_0004808 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 2.27e-03 | 97 | 79 | 3 | EFO_0007878, EFO_0009458 | |
| Disease | Psychotic Disorders | 2.55e-03 | 101 | 79 | 3 | C0033975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KWTWSAVRGGAAGED | 16 | O75410 | |
| WGWGGEDDDIFNRIS | 276 | O60909 | |
| GADSLEAWTSAVGKW | 771 | Q8WWN8 | |
| EGLGWDGSALEFNWH | 36 | Q53TN4 | |
| GAGGVEGAEWWATQA | 716 | Q6UVK1 | |
| WNEEGKAVWGESGEL | 471 | Q86V21 | |
| SEFGNWALGLWTEEG | 681 | Q8IUX7 | |
| GLTDSDGSWKWVDGT | 236 | P07307 | |
| WVASDGWGALESVVA | 291 | Q14416 | |
| GAWEWSIDTEAGGGR | 81 | P86434 | |
| FEGLGSLWDLNLGWN | 166 | P35858 | |
| GESFGSRWDTDAAWG | 366 | Q8N6H7 | |
| GARDWTEEWLSEGFA | 491 | Q8N6M6 | |
| GWTALRSAAWGGHTE | 611 | Q9ULJ7 | |
| GSGWLDDLQIHGWDS | 46 | P29016 | |
| NAFWGWGGEDDDLWN | 291 | O43286 | |
| GGAAGLGELRSWWEV | 6 | Q9BXF3 | |
| ISGWWSSDDNLDGEA | 201 | Q9Y2H0 | |
| LWAGGQTSEGTWAGD | 1191 | Q5H9R4 | |
| TWAGDKASGGAWTGA | 1201 | Q5H9R4 | |
| WVGEEAIGGSWTGAE | 1256 | Q5H9R4 | |
| GDSWAGTGDQASGWF | 1496 | Q5H9R4 | |
| ESGAGIWSWDGDATT | 1846 | Q5H9R4 | |
| GDGDGWVSLAELRAW | 91 | Q96D15 | |
| DDDLWSSRGSGGWGV | 401 | Q96PE2 | |
| LLTWDEDGDFGDAWA | 656 | Q96JG8 | |
| TENGQVWSWGDGDYG | 621 | O95714 | |
| LDDEGTAGGWLFWDD | 2636 | O43451 | |
| TAGGWLFWDDGQSID | 2641 | O43451 | |
| WDAEEFGLLGSTEWA | 421 | Q04609 | |
| GGREWLIGNSVTWAD | 136 | O60760 | |
| DGAWLLAGIISWGEG | 251 | Q9GZN4 | |
| SEAWATLGWAAAGGF | 301 | P29376 | |
| SGLVHWGADTWGSVE | 91 | A5PLL7 | |
| LWIGLNDLDTSGGWQ | 296 | Q9UBG0 | |
| CDLLWSDPDDRGGWG | 196 | P62714 | |
| CDLLWSDPDDRGGWG | 196 | P67775 | |
| GIVWEWENDGGAWTA | 106 | Q86Y01 | |
| DEADQGGWLAAFWKD | 756 | Q9H0A0 | |
| WEGSSGAMWGDDRGT | 681 | Q86Y26 | |
| EEQWWWATLLDEAGG | 41 | Q13882 | |
| VTGEDRLGWGSGWDV | 606 | Q99575 | |
| PDLLGGWAAWTETAA | 1031 | O14976 | |
| ATVGAAAWWFIAADG | 846 | P16615 | |
| GKGYWSDWSEEASGI | 306 | P40189 | |
| AFWGWGGEDDDLWNR | 286 | Q9UBX8 | |
| WARGQGSGWLDELQT | 41 | P29017 | |
| GSGWLDELQTHGWDS | 46 | P29017 | |
| EAGGEAEWAEPWDGA | 31 | Q495W5 | |
| VFLDGTGWEGGDEWI | 491 | Q8NBF6 | |
| TGWEGGDEWIRAQFA | 496 | Q8NBF6 | |
| WLGDGLLLSGGDKWS | 131 | Q9HBI6 | |
| WLGEGILLSGGDKWS | 131 | Q9HCS2 | |
| WLGDGLLLSAGDKWS | 131 | P78329 | |
| WGDQADGALEVGAPW | 151 | P34998 | |
| VWSWDEGFLEAGSQG | 431 | Q6UWL6 | |
| WLGDGLLLSAGEKWS | 131 | Q08477 | |
| HEGSWGTICDDSWDL | 736 | Q86VB7 | |
| LASEWATKDGRGTWG | 51 | Q5T0J3 | |
| LSRDAAISGDEGWWA | 71 | Q16584 | |
| ASYLWDLGDGGWLEG | 1496 | P98161 | |
| GLDWCNAGWLSDGSV | 201 | P10915 | |
| GDIIGSWFWAGEEDR | 776 | Q5JY77 | |
| AAADGSLQWEVGGWR | 26 | Q96GQ5 | |
| LWEAAQGAVDSWRGG | 6641 | Q8WXH0 | |
| DAAVSGDEGWWAGQV | 71 | Q5TCX8 | |
| GDWALGKESSPGWSD | 1281 | Q5QGS0 | |
| LAAAWSSGPAGDWEG | 316 | Q8NGU9 | |
| EAGTWSLWGKEDESL | 866 | Q9UL54 | |
| LGEDGWIRVQWDTGS | 626 | Q9BVR0 | |
| GGEAAQAEAWAWLAA | 1256 | Q12769 | |
| EVGSAGASSWWDVGA | 201 | Q8IXZ3 | |
| GASSWWDVGAGWIDV | 206 | Q8IXZ3 | |
| GDSDSTAAIAGCWWG | 301 | P54922 | |
| AVEQTWGWGDGSSHG | 96 | Q0VD83 | |
| TWEGSSEAGLDWAGA | 266 | Q9Y3P4 | |
| KVCWTSGWGATEDGA | 336 | P57727 | |
| DDELWLGDSGITNWD | 101 | Q96A61 | |
| DWRWTELAAGSGALF | 171 | Q8N2M4 | |
| EEAGSRSAGWGLAEW | 186 | Q6ICB4 | |
| EGAVSGGWGAWENST | 31 | Q6ZNH5 | |
| ALVGSDAESWGWDLG | 131 | Q96A44 | |
| GGSWGSVCDDDWDVV | 76 | Q8WTU2 | |
| HSGLWGTVCDDDWGL | 206 | Q8WTU2 | |
| AALLGSNSESWGWDI | 121 | Q99619 | |
| SNSESWGWDIGRGKL | 126 | Q99619 | |
| EALWAELKAGAESGW | 306 | O43280 | |
| AESGWDFSSRWLIGG | 316 | O43280 | |
| ALHGGAWGTVCDDAW | 571 | Q4G0T1 | |
| VDVQEAGAGWWVGAA | 326 | Q14142 | |
| WDGGDFGSVGSTEWL | 476 | Q9UP52 | |
| LGSWSLGDWGAEACT | 11 | P35625 | |
| GDWWEARSIATGKNG | 126 | P07947 | |
| WDAEEFGLLGSTEWA | 411 | Q9Y3Q0 |